Discover 336 paid clinical trials in Albuquerque, New Mexico. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 336
Active & Responsive
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
for
Metastatic Breast Cancer
Location: Albuquerque NM, Rio Rancho NM, Las Cruces NM, Mesa AZ,
Sponsor: American Society of Clinical Oncology
Sex: All
Age: 65+
Code: NCT06377852
Phase3, Recruiting
Active & Responsive
Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
for
Major Depressive Disorder
Location: Albuquerque NM, Oklahoma City OK, Edmond OK, Dallas TX,
Sponsor: Neumora Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06058013
Phase3, Recruiting
Active & Responsive
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Location: Albuquerque NM, Scottsdale AZ, Golden CO,
Sponsor: Orchestra BioMed, Inc
Sex: All
Age: 18+
Code: NCT06059638
Recruiting
Active & Responsive
VK2735 for Weight Management Phase 3
for
Weight Loss
Location: Albuquerque NM, Flagstaff AZ, Tucson AZ, Scottsdale AZ,
Sponsor: Viking Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07104500
Phase3, Recruiting
Active & Responsive
Psilocybin for Major Depressive Disorder (MDD)
for
Depressive Disorder, Major
Location: Albuquerque NM, Denver CO, Murray UT, Plano TX,
Sponsor: Usona Institute
Sex: All
Age: 18+
Code: NCT06308653
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
for
Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer,
Location: Albuquerque NM, Salt Lake City UT, Houston TX,
Sponsor: VM Oncology, LLC
Sex: All
Age: 18 - 70+
Code: NCT03556228
Phase1, Recruiting
Active & Responsive
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
for
Relapsed or Refractory Multiple Myeloma
Location: Albuquerque NM, Abilene TX, Salt Lake City UT,
Sponsor: Celgene
Sex: All
Age: 18+
Code: NCT05519085
Phase3, Recruiting
Active & Responsive
Study to Assess the Safety and Effectiveness of NMRA-335140-501
for
Major Depressive Disorder
Location: Albuquerque NM, Phoenix AZ, Oklahoma City OK, Edmond OK,
Sponsor: Neumora Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06029439
Phase3, Recruiting
New
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)